Pentosan Reduces Osteonecrosis of Femoral Head in SHRSP

References

• Hirota Y. Etiology of idiopathic osteonecrosis of the femoral head: nationwide epidemiologic studies in Japan. In: Osteonecrosis: Etiology, Diagnosis, and Treatmen, 1997, 51–58.
   Google Scholar
• Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T. DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 2005,44:456–460.
   PubMed Web of Science ®Google Scholar
• Fisher DE.. The role of fat embolism in the etiology of cortico-steriud-induced avascular necrosis : clinical and experimental results. Clin Orthop 1978;130:68–80.
   PubMedGoogle Scholar
• Zhang G, Qin L, Sheng H, A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 2009;44:345–356.
   PubMed Web of Science ®Google Scholar
• Murata M, Kumagai K, Miyata N, Osaki M, Shindo H. Osteonecrosis in stroke-prone spontaneously hypertensive rats: Effect of glucocorticoid. J Orthop Sci 2007:12:289–295.
   PubMed Web of Science ®Google Scholar
• Arlet J. A traumatic necrosis of the femoral head: General report. In: Schoutens A, Arlet J, Gardeniers JWM, Hughes SPF, eds., Bone Circulation and Vascularization in Normal and Pathological Conditions. New York: Plenum, 1993, 235–240.
   Google Scholar
• Atsumi T, Muraki M, Yoshihara S, Kajihara T. Posterior rotational osteotomy for the treatment of femoral head osteonecrosis. Arch Orthop Trauma Surg 1999;119:388–393.
   PubMed Web of Science ®Google Scholar
• Sugioka Y. Transtrochanteric anterior rotational osteotomy of the femoral head in the treatment of osteonecrosis affecting the hip: a new osteotomy operation. Clin Orthop Relat Res 1978;130:191–201.
   PubMedGoogle Scholar
• Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: Ten years later. J Bone Joint Surg Am 2006;88:1117–1132.
   PubMed Web of Science ®Google Scholar
• Yamori Y. Development of the spontaneously hypertensive rat (SHR) and of various spontaneous rat models, and their implications. In: de Jong W, ed., Handbook of Hypertension, Experimental and Genetic Models of Hypertension, Volume 4. Amsterdam: Elsevier Science Publishers BV; 1984, 224–239.
   Google Scholar
• Wada M, Kumagai K, Murata M, Yamashita S-Y, Shindo H. Warfarin reduces the incidence of osteonecrosis of the femoral head in spontaneously hypertensive rats. J Orthop Sci 2004;9:585–590.
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Hirano T, Sagara K, Nishimura Y. Idiopathic necrosis of the femoral epiphyseal nucleus in rats. Clin Orthop 1992;277:31–40.
   PubMedGoogle Scholar
• Hirano T, Iwasaki K, Sagara K, Nishimura Y, Kumashiro T. Necrosis of the femoral head in growing rats. Occlusion of lateral epiphyseal vessels. Acta Orthop Scand 1989;60:407–410.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Kumagai K, Osaki M, Murata M, Tomita M, Miyata N, Hozumi A, Niwa M. Osteonecrosis of femoral head in the stroke-prone spontaneously hypertensive rats, especially old rats. Clin Exp Hypertens 2008;30:689–697.
   PubMed Web of Science ®Google Scholar
• Boss JH, Misselevich I, Peskin B, Zinman C, Levin D, Norman D, Reis DN. Postosteonecrotic osteoarthritis-like disorder of the femoral head of rats. J Comp Pathol 2003;129:235–239.
   PubMed Web of Science ®Google Scholar
• Yagi S, Aihara K, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M, Matsumoto T. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS- independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency. Circ Res 2008;102:68–76.
   PubMed Web of Science ®Google Scholar
• Ichiseki T, Ueda Y, Katsuda S, Kitamura K, Kaneuji A, Matsumoto T. Oxidative stress by glutathione depletion induces osteonecrosis in rats. Rheumatology (Oxford) 2006; 45:287–290.
   PubMed Web of Science ®Google Scholar
• Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 2004;50:3387–3391.
   PubMed Web of Science ®Google Scholar
• Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Masada T, Kobayashi A, Asada A, Takaoka K. Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci 2008;13:463–468.
   PubMed Web of Science ®Google Scholar
• Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003;92:81–87.
   PubMed Web of Science ®Google Scholar
• Nagasawa K, Tada Y, Koarada S, Tsukamoto H, Horiuchi T, Yoshizawa S, Murai K, Ueda A, Haruta Y, Ohta A. Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant. Lupus 2006; 15:354–357.
   PubMed Web of Science ®Google Scholar
• Cheras PA. Role of hyperlipidemia, hypercoagulability, and hypofibrinolysis in osteonecrosis and osteoarthritis. In: Urbaniak JR, Jones JP Jr, eds., Osteonecrosis:Etiology, Diagnosis, and Treatment. Rosemont, IL: American Academy of Orthopedic Surgeons, 1997, 97–104.
   Google Scholar
• Ghosh P. The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Semin Arthritis Rheum 1999;28:211–267.
   PubMed Web of Science ®Google Scholar